Pharmaceutical Preparations · DE · CIK 906709
Nektar Therapeutics develops and researches new drug candidates for various therapeutic areas
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 3 sold $399K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Robin Howard WPresident & CEO | Sell | 423 | $73.00 | $31K |
| Feb 18, 2026 | Zalevsky JonathanChief R&D Officer | Sell | 180 | $73.00 | $13K |
| Jan 20, 2026 | Zalevsky JonathanChief R&D Officer | Sell | 3,867 | $35.67 | $138K |
| Nov 25, 2025 | Robin Howard WPresident & CEO | Sell | 2,207 | $54.28 | $120K |
| Nov 25, 2025 | Zalevsky JonathanChief R&D Officer | Sell | 1,157 | $54.28 | $63K |
| Nov 25, 2025 | Wilson Mark AndrewChief Legal Officer | Sell | 630 | $54.28 | $34K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.